Interactions among membrane transport systems: anthracyclines, calcium antagonists and anti-estrogens.
D000818:Animals; D000903:Antibiotics, Antineoplastic; D001692:Biological Transport; D002121:Calcium Channel Blockers / Q000378:metabolism / Q000627:therapeutic use*; D003630:Daunorubicin / Q000378:metabolism / Q000627:therapeutic use; D004317:Doxorubicin / Q000378:metabolism / Q000627:therapeutic use; D004351:Drug Resistance; D004965:Estrogen Antagonists / Q000378:metabolism / Q000627:therapeutic use*; D007700:Kinetics; D007941:Leukemia P388 / Q000188:drug therapy / Q000378:metabolism; D051379:Mice; D009279:Naphthacenes / Q000378:metabolism / Q000627:therapeutic use; D009543:Nifedipine / Q000031:analogs & derivatives / Q000378:metabolism / Q000627:therapeutic use; D009568:Nitrendipine; D013629:Tamoxifen / Q000378:metabolism / Q000627:therapeutic use; D014700:Verapamil / Q000378:metabolism / Q000627:therapeutic use
D000903:Antibiotics, Antineoplastic; D002121:Calcium Channel Blockers; D004965:Estrogen Antagonists; D009279:Naphthacenes; D013629:Tamoxifen; D004317:Doxorubicin; D009568:Nitrendipine; D014700:Verapamil; D009543:Nifedipine; D003630:Daunorubicin